Literature DB >> 24549483

[Botulinum toxin in dermatology].

W G Philipp-Dormston1.   

Abstract

Treatment with botulinum toxin (BTX) type A has become increasingly important in various clinical areas in dermatology. Particularly popular is the therapy with BTX for hyperkinetic lines associated with muscles of facial expression in aesthetic dermatology, which is the most frequent wrinkle treatment undertaken worldwide. Therapy with BTX also ranks high in curative dermatology. Injections with BTX are the most effective nonoperative therapy for hyperhidrosis. Common indications for the treatment of hyperkinetic lines with BTX are presented in this publication. Therapy of glabellar lines, which has received regulatory approval, is presented in detail. In the second part, treatment of focal hyperhidrosis with emphasis on axillary hyperhidrosis is addressed. In the hand of the experienced practitioner, treatment with BTX in a suitable area of indication is a very safe and effective procedure that leads to remarkable treatment results, associated with a very high patient satisfaction.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24549483     DOI: 10.1007/s00105-013-2744-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  17 in total

1.  Botulinum toxin type A therapy during pregnancy.

Authors:  William J Newman; Thomas L Davis; Bimal B Padaliya; Bismal B Padaliya; Cassondra D Covington; Chandler E Gill; Anna I Abramovitch; P David Charles
Journal:  Mov Disord       Date:  2004-11       Impact factor: 10.338

2.  International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I: Upper facial wrinkles.

Authors:  B Ascher; S Talarico; D Cassuto; S Escobar; D Hexsel; P Jaén; G D Monheit; B Rzany; M Viel
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-11       Impact factor: 6.166

Review 3.  The protein load of therapeutic botulinum toxins.

Authors:  A Pickett; R O'Keeffe; N Panjwani
Journal:  Eur J Neurol       Date:  2007-04       Impact factor: 6.089

Review 4.  Botulinum neurotoxin type A in facial aesthetics.

Authors:  Koenraad L V De Boulle
Journal:  Expert Opin Pharmacother       Date:  2007-06       Impact factor: 3.889

Review 5.  [Botulinum toxin in focal hyperhidrosis. An update].

Authors:  C Hosp; M K Naumann; H Hamm
Journal:  Hautarzt       Date:  2012-06       Impact factor: 0.751

6.  Effective treatment of frontal hyperhidrosis with botulinum toxin A.

Authors:  I Kinkelin; M Hund; M Naumann; H Hamm
Journal:  Br J Dermatol       Date:  2000-10       Impact factor: 9.302

Review 7.  Upper- and mid-face anti-aging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus--part 1.

Authors:  Herve Raspaldo; Martine Baspeyras; Philippe Bellity; Jean-Marie Dallara; Veronique Gassia; Francois-Rene Niforos; Lakhdar Belhaouari
Journal:  J Cosmet Dermatol       Date:  2011-03       Impact factor: 2.696

8.  Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines.

Authors:  Jean D Carruthers; Nicolas J Lowe; M Alan Menter; John Gibson; Nina Eadie
Journal:  Plast Reconstr Surg       Date:  2003-09-15       Impact factor: 4.730

Review 9.  Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.

Authors:  Koenraad De Boulle; Steven Fagien; Boris Sommer; Richard Glogau
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

10.  Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A.

Authors:  Roger M Benoit; Daniel Frey; Manuel Hilbert; Josta T Kevenaar; Mara M Wieser; Christian U Stirnimann; David McMillan; Tom Ceska; Florence Lebon; Rolf Jaussi; Michel O Steinmetz; Gebhard F X Schertler; Casper C Hoogenraad; Guido Capitani; Richard A Kammerer
Journal:  Nature       Date:  2013-11-17       Impact factor: 49.962

View more
  1 in total

1.  [Hyaluronic acid fillers in dermatology].

Authors:  Wolfgang G Philipp-Dormston
Journal:  Hautarzt       Date:  2018-06       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.